ABRILADA adalimumab 40 mg solution for injection vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8e790bd27550e3f8
Product Name: ABRILADA adalimumab 40 mg solution for injection vial
Artg Id: 334499
Artg Name: ABRILADA adalimumab 40 mg solution for injection vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2021-02-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-01849-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01250-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8e790bd27550e3f8

Type

Standard